pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-497 |
Genomic Coordinates | chr17: 7017911 - 7018022 |
Synonyms | MIRN497, hsa-mir-497, MIR497 |
Description | Homo sapiens miR-497 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-497-3p | ||||||||||||||||||||||||||||
Sequence | 64| CAAACCACACUGUGGUGUUAGA |85 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC30A4 | ||||||||||||||||||||
Synonyms | ZNT4, znT-4 | ||||||||||||||||||||
Description | solute carrier family 30 member 4 | ||||||||||||||||||||
Transcript | NM_013309 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC30A4 | |||||||||||||||||||||
3'UTR of SLC30A4 (miRNA target sites are highlighted) |
>SLC30A4|NM_013309|3'UTR 1 TTTTATGTATTTTGGGAACTCCTGCCTTATTTATCCTGCAGTCACAGACTTGAGAGCAATAAATGCAAACCTAAATGAGA 81 AAATGGAATCCCTGACAGCTGTGTCCGTATCAAGCATCAGTCTCTCAAACAGTTGCCCCAGCCTGACAGTGCTAGTCTCT 161 GTTTAATGGTAAAAGGAGACTTTGCCATAATTTTCAGATGAAGATGTTTCCCAAACACTGTTTACAGAATGAGATGTGAC 241 TCTACAGATACCTCATAGAAGACAATCCAAGATCATACTTCATTAACTTGACAGAGTACGTGTCTTAAAGGAAGCATCAA 321 GAATTCAATATTTGCATTTAAAAATACTTTTTAAGGCCATTTTATATTAAGCCAGTGCTGGAAAACTGAATTTTTTTTAT 401 TATGTATAATAATCTCGACACCCAGCTTCTGGAATTGCTGCTTTCTTTTTACAGAAATTACTACCCAACAGATTTCAGGA 481 AGTACTAGTAGTTATCCCAAAAGTGGAATAAGCATGTATTCCTAAGTGTTTCAGAAATGTTTTATTTCACACATAAGTCT 561 TAATGTTATTGTTATGATTATACTTTATAAACAACCTTTTCCAGATGCTACAGGGTTTTGAATCTCAAAGTTAACATTTT 641 TCATTATTTGTAATCTTAGAACCAAATCTTTATTTATTGTGGTCACTGTTATTAAATGATTTAGGAAATACTTTCAATAT 721 TATTCTGAATGGCTGAAGTTAGTCTTAAACTCAAATTACTATATGATGATTTAAAACAAAATAAAAGAGCGAGGATGGGG 801 GTTGGAGTTTCAGGTTTATGTCTTCCCGACATCACTTTTATCATTCATGAAATTGTCTTAAAAAAGCAAGAGACTGCAAA 881 ATGTAAACAGTAATCTTCTGTCCCTTTAAGAACTGCCAACAATTTGTACAAAAAATGTGGTACGTTGGTTCCTGCCTCCA 961 CTCCAGGTCATCTGTGTGTTTAGCCTTTCAGGGTAAACTCTAGAGGGTTCAGTTTATAATTCCCACCTTTCACATATAGT 1041 TCAACAACATTAATCCAGAGAGAATTTTATGTTTTATGATATGGGTTATGTTTTATTATATATTTTATGTTTTATGATAT 1121 GGGTTAGGGATTCTCCATGGACTCCAGAAACCCTAAAATACAATTTTGAGGTTTTCCAATAATACCATAGCAGAAATGTC 1201 CAAGGGGTTGGGGGAAGATATTACTTTGAGAAAACAGAAATGTAAAGGATTTTTGACCTTATATATGTGTGTGGTTTTGT 1281 TTTTGTTTTTGTTCTTGAGAGAGTCTCACTCTGTCACCCAGGCTGGAGTGCAGTGGCGTGACCTCTGCTCACTGTAACCT 1361 CTGCCTCCTGGGTTCAAGTGATTCTTCTGCCTCAGCCTCCCAACTAGCTGGGACTACAGGTACACCACACCCAGCTCATT 1441 TTTTTGTATTTTTAGTAGAGACAGGGTTTTGCCACATTGGCCTGTCTGGTCTTGAACTCCTGACCTCAGGTGATCCGCCT 1521 GCCTTGGCCTTCCAGAGTGCTGGGATTACAGCATGAGCCACCATGCCTGGCCTGTATGTGTGTGTTTTAAAGCACTAGAT 1601 AGGGATGGACATTAAATCTGTGTTGCAGGGAAACTAAACAGAGGTTTCCAAACTGAAGGCAACCTAATTGTAAATGCCTG 1681 TGTTAAAGAGGCAGCTTGACTGTTCATGTTTCATTTTGCAACCATTGGTTTTGAGATTATCTTTTATGCACATTTGGAGT 1761 CCCTTTTCAACAGTGACAGTTTCTTACACGAAGAATGGATATGGTTATTGGGCTCCTCTAAGAATCAGAGTAGGGTAACA 1841 ATGTACCAGGCAAATTGTAAGTTGAAATTCTAGATAAGCATGCAGATGACTTACAATATAAATGAAGAATAGGAAACATT 1921 TTATCTTCTTACCAAGTACCTTACTATAAGTAAACCTAAGATAAGAAAACCCAGATTTACCTATAAGATTGTTGGGAGTT 2001 AATGGTGTCAATAAAAGGATTGATGGTCCCTCTAATGAAACCCAGTAGATGTTTGTTGAATTGAACTGAAAATTTATGTG 2081 GCCAGACACAGTGGCTCATGCCTGTAATCTCAGCATTTGGGGAGGCAAAGGTGGAAGTATCCCTCGAGGCCAAGAGTTCA 2161 TGACCAGCCTGGTCTTTTGTAGAGACCCTGTCTCTACAAAAATATAAAAATCAGCCAGGCGTCGTGCACACCTGTAGTAT 2241 CAGCTACTTGTAAGGCTGTGGCAGAAGTGCTTTAGCCCAGGAGGTTGAGGCTGCAGTGAGCCATGTCCACACCATTGCAC 2321 TGCAGCCTGAGTAACAAAATGAGACCCTATCTCAAAAACAAAAAGGAAAAGAAAATATACATGATGGGATTCCTATTGTG 2401 AAGTCATTTAAAATAATGACTTGAATTTCTCAGAAATTTCAGGAGCATATAAACTATTTAAATCAAAATATTCTTACATA 2481 TAGAAACCAAGTAAGAATAAATGAGAGATATTTCAGTGGACATCTGGACATATTTATGGACTTTGAGTATCTAGCAAGTA 2561 GAAAGGAAAAAAATATTCATCATACTCTAATCATTTTTTTATATCTATTGAGCTTGTTTCTTGTAAACTTTTCTTTATCT 2641 TATAAAGGCATATCTCGCTTTTGTATCGACCTGTTCCTTAAAAAATGTATTTGATAAAACAGGCTAAAATTCATTTGAGT 2721 ATTGAAAAGAATTCTTTTTTTTTTTTTAAGATGGTGTCTCACTGTCACCCAGGCTGGAGTGCAGTGGCACAGTTGGGCTC 2801 ACTGCAGCCTCTGCCTCCCAGGCTCAAGTGGTCCTCCCATCTCAGCCTCCCAAGTAGCTGGTACCACAGGCATGCACCAC 2881 CACACCCAGCTAATTTTTTGTATTTTTGGTAGACACAGTGTTTCACCATGTTGCCCAGGCTGGTCTTGAACTCCTGAGCT 2961 CAAGTGATCTGCCCACCTCGGCCTCCCAAAGTGCTGGGCTTATGGGCATGAACCACTGTGCCCAGCCAAAAAGAATCCTT 3041 TTGTAAAATACAGAAACACTGCAAACCTTTGTAAATCTTTTTTTTTTTTTTTTTTTTTTTTTTTTAATGAGATGGGGTCT 3121 CCCTATGTTGCCCAGGCTGGTCTTGAGCTCCTGGGCTCAAGAAATCCTTCCACCTCGGGCTCCCAAAGTGCTGAGATTAC 3201 AGGGTGTGAGCTACCGCACCCAGCCATGAAAACTTCTGTAAATCTTAACTATCGTGTTCTGCTTAAAGTGAGGTACACAT 3281 AAAGTTTCCTGTGCTTTGTTTTTGTAGGAAAAAGTACATAGTTTGTATCTTTACCTTACGGAGTCTATGAGATTTGAGAA 3361 TTTGATTTCACTTTTTGTAACTTAACCCACAGAAAAGGACATTAACTTAGCAGATAGGACCAAGGACTGAATGACTTCTG 3441 ACAAAAAGCGTTTGGTCTATCCTTCACTTGTTGAGCTACAACCATGCATTACACTTCTCAGCTGAGCTCTCAAAGAGCTC 3521 TATGCCCTGTGAAAAGCAGTGGCTGAGTTGGATGAACACATAGCATTATTAATTTTGCACTGGGAAAACAGATTATGACA 3601 GGACCACAGACCACAATATAAAAACTTGGCAGTTCTTTGGTGTGATATATTTTAATTAGTATTTGCAAATAATCAGAGTT 3681 ACTTGTGTACATAAACGTGTGTTTCACAACTATGGCCAGATGCAACCTTTTGGTCTGTTTCAGGAAAAGACCTATTATTC 3761 CACTAACAATTATGCTGCCTTAGAAACATAATGGGAGTGTAATTGAAGAAAGCATGTCTCAGAAGGTTTTGATATGCAGA 3841 ACTGGAAGCTATTGTAATTCCTACATACATTTCCATTAGCTATGCCTTATGTAATGTGAGTGCAGATTTTTACAACTTAG 3921 AGTTCCCATCAGTGTTTTTTTGCCACATCACCGGGTTTCTTATTTTACTGTTTTCTTTTCAACTTTGGGTGCTTTATTTC 4001 CATTCTCTAAAACTAAGTTTCTTGCTCTTACGAGACTTAGTGTTCCTTTTGAACCCAGGTGTTCCACCTGACAGTGTTTG 4081 TCTTTCATAGACTTTCCAGAATAGACATAGTCAAGATCAGACACGTGAGCTTCTCTCTCATTTTAATGTGAGGAAAATCA 4161 TCTTTCAGAGACAAGGCACCGCTTAGAAATGTATGTCCAGGTATGAAAGAACCTTTTTAAAATGGCTGGTTGTTCCAGAT 4241 CCAGATTTCTCTGCACACTGGACTTCGTAGAGTAAGTGTGGTAGACAAAGAGACTACACTGCACAACCACCAGTGAATAT 4321 CATTGCTAAGAAGACTTTGGGTCGTGTTTCTCAGCCACTCTCACAGCTTTTGTAGACTTATTTGATTTTGAAACAAGCAG 4401 TTAGCTAAATCTATTTTCCTTTTATGCATATATGTTAATTGGCTCAACTTAATATGGTGTTCTTACAGAATATGAGCCCA 4481 TTTGAAATAAGGTTTTAGGCAATTTTGCTGTTGGCTCTGATTTGTATATAGCAAATTTAAAGTTACAGAGTGTTTCCTAG 4561 ATAGAAGATTAGTTCATTTGGTTCATTTTGTCTTTGAAGCAAGCCAAGCTCATGAGCCAGTTGGTTATTTGTCATAAATG 4641 AACACCCATCACTATATGCTATGTTGAGGGGAGGCAAGTCTGATCTTCGAATAATTGATAAAGTTTAATATCTTTGTAGC 4721 CAAAATACAATTTGCAAACCCTAACTCCAGATGTGTCGTATGAATCTTGACAACCAGGTCTTGAGATTTGTTTTACTGAT 4801 TGCCAATCAGGTATATTATTTGTGATGTTCGTGGGAGCATGCAAATTAGAAGACAGTGTTGTGGGAGTTCCTCAGTATTG 4881 AATTACATGTGTGCACTCAGGCCTGCCAGTCACTGAATTCTGACTTGTAAAGGGTTTAACCTGCTGTTCCAATCATTGAG 4961 GACCAATTTGCTTTTTGATAAGATTGGAAAACATTTATGGAGACTTTCCCAGTTAAATCTATGACAGTGTCCACTTAAAT 5041 AGTGCAATTTAGTATATTCTCAGATAACTGCAACACAAAATTGAAATGTGCCAGTATGTCATCTTTCTACCTGGAAGATA 5121 CTGTATATTTGGAAAGTTTATGCTTCTCTCAATAAATACATGTTATTAAATAAGCCATATCACAGTTTAAGAAATTGTAT 5201 ATACTTTATCATATGCCCTTTCAGAAACCAGGTATTTTGCATATGATTGATTTTAGAAAGATTTTGAAGCTGGGGTTTGT 5281 CCATGTTAATTAAGATCAAAGTATATATATATATATATATATGTGCTGTATTTGCAACTTTCACATTGTAATTTCCTATA 5361 CACTTATTAAAGTATTGTTTTGCCATGTGGTTTATTAAATAAAAATGTACAGTCTCTTAAATATCTGCTCTTTTTATTAA 5441 GTAATATTAGTAGGCCTAAAAACATTGTTCTTAAAAGAAAATCTTTTATAATTATAATGTCATTTTATAATGCCCTCTTA 5521 TATGTTTAAGAAATAAAACTGAAAAAAATCAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000261867.4 | 3UTR | UGUGGUUUUGUUUUUGUUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
95 hsa-miR-497-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT092955 | CYP2U1 | cytochrome P450 family 2 subfamily U member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT124568 | PRRC2B | proline rich coiled-coil 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT125196 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | ![]() |
![]() |
2 | 4 | ||||||
MIRT147296 | KPNA2 | karyopherin subunit alpha 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT163999 | KIAA1109 | KIAA1109 | ![]() |
![]() |
2 | 4 | ||||||
MIRT252495 | NWD1 | NACHT and WD repeat domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT357969 | GRPEL2 | GrpE like 2, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT443007 | TRIOBP | TRIO and F-actin binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT443524 | NETO1 | neuropilin and tolloid like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443573 | EVX2 | even-skipped homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443656 | BACH1 | BTB domain and CNC homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460670 | KRT10 | keratin 10 | ![]() |
![]() |
2 | 8 | ||||||
MIRT464761 | UBE2N | ubiquitin conjugating enzyme E2 N | ![]() |
![]() |
2 | 2 | ||||||
MIRT465032 | LINC00598 | long intergenic non-protein coding RNA 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465040 | TTC39C | tetratricopeptide repeat domain 39C | ![]() |
![]() |
2 | 2 | ||||||
MIRT468667 | SEC62 | SEC62 homolog, preprotein translocation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT473694 | MAPK8 | mitogen-activated protein kinase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT477618 | EFNA3 | ephrin A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480506 | C11orf57 | chromosome 11 open reading frame 57 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480592 | BUB3 | BUB3, mitotic checkpoint protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT486915 | ZNF398 | zinc finger protein 398 | ![]() |
![]() |
2 | 6 | ||||||
MIRT487770 | ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | ![]() |
![]() |
2 | 16 | ||||||
MIRT493265 | MDFIC | MyoD family inhibitor domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT495271 | SLC1A2 | solute carrier family 1 member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT495309 | CHST12 | carbohydrate sulfotransferase 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496681 | DPP6 | dipeptidyl peptidase like 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT496891 | FOXP1 | forkhead box P1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497330 | IRF4 | interferon regulatory factor 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498272 | KIAA1644 | KIAA1644 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498634 | CHD4 | chromodomain helicase DNA binding protein 4 | ![]() |
![]() |
2 | 10 | ||||||
MIRT500581 | USP53 | ubiquitin specific peptidase 53 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500751 | TMPPE | transmembrane protein with metallophosphoesterase domain | ![]() |
![]() |
2 | 6 | ||||||
MIRT509668 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 10 | ||||||
MIRT510919 | PSMA2 | proteasome subunit alpha 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519118 | CEP76 | centrosomal protein 76 | ![]() |
![]() |
2 | 2 | ||||||
MIRT526193 | ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT526746 | HLA-DOB | major histocompatibility complex, class II, DO beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT527270 | FBLN2 | fibulin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528198 | PLEKHM2 | pleckstrin homology and RUN domain containing M2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528330 | TBC1D22B | TBC1 domain family member 22B | ![]() |
![]() |
2 | 2 | ||||||
MIRT530346 | GABRB3 | gamma-aminobutyric acid type A receptor beta3 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT533627 | TMX3 | thioredoxin related transmembrane protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533738 | TMEM200C | transmembrane protein 200C | ![]() |
![]() |
2 | 2 | ||||||
MIRT533779 | TMEM133 | transmembrane protein 133 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534317 | SKIDA1 | SKI/DACH domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538438 | COG5 | component of oligomeric golgi complex 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539156 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539474 | ADARB2 | adenosine deaminase, RNA specific B2 (inactive) | ![]() |
![]() |
2 | 2 | ||||||
MIRT539620 | SHISA9 | shisa family member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539650 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT540346 | OPHN1 | oligophrenin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540412 | PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541200 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541395 | CDC27 | cell division cycle 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546443 | SNX5 | sorting nexin 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547369 | MSI2 | musashi RNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT553288 | TSPAN3 | tetraspanin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554402 | SERP1 | stress associated endoplasmic reticulum protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557822 | FOXN2 | forkhead box N2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568530 | ANP32E | acidic nuclear phosphoprotein 32 family member E | ![]() |
![]() |
2 | 2 | ||||||
MIRT569508 | THYN1 | thymocyte nuclear protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570707 | FAM69A | family with sequence similarity 69 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT608376 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT608483 | NKTR | natural killer cell triggering receptor | ![]() |
![]() |
2 | 6 | ||||||
MIRT613533 | TRA2B | transformer 2 beta homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT616601 | ELP2 | elongator acetyltransferase complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618166 | DUSP18 | dual specificity phosphatase 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632059 | CEP135 | centrosomal protein 135 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647379 | ZDHHC23 | zinc finger DHHC-type containing 23 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648366 | POTED | POTE ankyrin domain family member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT651075 | ZNF518B | zinc finger protein 518B | ![]() |
![]() |
2 | 4 | ||||||
MIRT653618 | SLC30A4 | solute carrier family 30 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653636 | SLC30A1 | solute carrier family 30 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654895 | POU2F1 | POU class 2 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656232 | MFSD6 | major facilitator superfamily domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659880 | CAPRIN1 | cell cycle associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660526 | ARL4C | ADP ribosylation factor like GTPase 4C | ![]() |
![]() |
2 | 2 | ||||||
MIRT666286 | SLC30A3 | solute carrier family 30 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686808 | SNX2 | sorting nexin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT695302 | TK1 | thymidine kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699737 | SERINC3 | serine incorporator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700794 | PIAS2 | protein inhibitor of activated STAT 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712270 | PPP1CB | protein phosphatase 1 catalytic subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT712617 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT714264 | RPL10A | ribosomal protein L10a | ![]() |
![]() |
2 | 2 | ||||||
MIRT715072 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715386 | TADA3 | transcriptional adaptor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716397 | NPAS1 | neuronal PAS domain protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725328 | NFASC | neurofascin | ![]() |
![]() |
2 | 2 | ||||||
MIRT725503 | GANAB | glucosidase II alpha subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT732913 | IRAK2 | interleukin 1 receptor associated kinase 2 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT734890 | SMAD3 | SMAD family member 3 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737328 | LINC02476 | long intergenic non-protein coding RNA 2476 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737544 | MALAT1 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ![]() |
![]() |
![]() |
![]() |
4 | 0 | ||||
MIRT755545 | PAK1 | p21 (RAC1) activated kinase 1 | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|